trending Market Intelligence /marketintelligence/en/news-insights/trending/U-ugGCfnXLdT1_1bOnTEIw2 content esgSubNav
In This List

ContraVir Pharmaceuticals chief medical officer steps down

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


ContraVir Pharmaceuticals chief medical officer steps down

ContraVir Pharmaceuticals Inc. said John Sullivan-Bolyai is stepping down as chief medical officer and taking on a new role in the company, effective Dec. 29.

Sullivan-Bolyai will serve as a part-time consultant to the company, where he will remain involved in strategic decisions as well as medical and clinical affairs.